Iron and Ruthenium Glycoporphyrins: Active Catalysts for the Synthesis of Cyclopropanes and Aziridines by C. Damiano et al.
FULL PAPER  
  
 
 
 
 
 
Iron and Ruthenium Glycoporphyrins: Active Catalysts for the 
Synthesis of Cyclopropanes and Aziridines 
Caterina Damiano, Sebastiano Gadolini, Daniela Intrieri, Luigi Lay*, Cinzia Colombo and Emma 
Gallo* 
 
Abstract: In view of the relevance of cyclopropanes and 
aziridines as synthetic building blocks as well as active parts in 
biological and pharmaceutical compounds, the development of 
sustainable synthetic procedures for obtaining these products 
continues to be a significant challenge. Herein, we report the 
synthesis of iron and ruthenium glycoporphyrins and their 
catalytic activity in promoting cyclopropanations and 
aziridinations by using diazo compounds and aryl azides as 
carbene and nitrene precursors, respectively. The number and 
location of carbohydrate units on the porphyrin skeleton 
modulated the shape- and diasteroselectivity of the reactions. 
Interestingly, while iron(III) glycoporphyrins showed good 
performances in alkene cyclopropanations, ruthenium(II) 
complexes performed better in aziridination reactions. Although 
none of the reported complexes induced enantiocontrol, 
probably due to the long distance between the chiral 
carbohydrate and the active metal centre, excellent trans-
diasteroselectivities were observed by using iron-
glycoporphyrins as cyclopropanation promoters.  
Introduction 
Three-membered ring compounds, such as cyclopropanes and 
aziridines, are valuable molecules due to their high chemical 
reactivity and their presence in the organic skeleton of biological 
and pharmaceutical products.[1] Thus, a large interest has been 
focused on the development of efficient synthetic procedures to 
obtain these classes of compounds. The direct reaction of 
alkenes with carbene [C(R2)R3] and nitrene [NAr] precursors, 
such as diazo compounds and aryl azides respectively, are 
atom-efficient strategies due to the formation of the eco-friendly 
N2 as the only stoichiometric by-product (Scheme 1).
[2] 
 
Scheme 1. Reaction of styrenes with either diazo compounds (path a) or aryl 
azides (path b). 
Among transition metal complexes, which have been used for 
mediating these transformations,[3] metal porphyrins represent a 
very powerful class of molecules,[4] whose properties can be 
modulated by introducing suitable substituents onto the 
skeleton. Carbohydrates are interesting bio-scaffold molecules 
for the porphyrin functionalisation, since their features can be 
exploited for varying the chemical nature of porphyrin ligands 
and in turn, the chemo-physical properties of the catalysts. 
Although glycoporphyrins have largely been described for 
biological and pharmaceutical applications,[5] their use as ligands 
in catalysis has been still limited.[6] 
Some years ago, we reported the synthesis and catalytic activity 
of different metal glycoporphyrins, which were very efficient in 
promoting benzylic C-H bond aminations by organic azides.[7] 
These promising results prompted us to also study the catalytic 
activity of metal glycoporphyrins in cyclopropanations and 
aziridinations of alkenes. The dependence of catalytic 
performances on the number and location of carbohydrate units 
on the porphyrin skeleton is here reported.  
Results and Discussion 
Considering that the molecular structure of the porphyrin ring 
plays an important role in determining the efficiency of the 
corresponding metal catalysts, mono and tetra glycosyl-
substituted porphyrins were synthesised to assess how the 
number and location of carbohydrate units can influence the 
catalytic activity of their relative ruthenium and iron complexes. 
First, porphyrins 2 and 3, showing one or four carbohydrate 
units on the para position of the meso-aryl group, were obtained 
by using minor modifications of a methodology already reported 
by us.[7] 
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Scheme 2. Synthesis of mono and tetra glycoporphyins 2 and 3.  
The direct reaction of cellobioside 1[8] with either F5TPPH2
[9] or 
F20TPPH2
[10] porphyrin afforded glycoporphyrins 2 and 3 in 60% 
and 40% yields, respectively (Scheme 2). From a synthetic point 
of view, the presence of one or four C6F5 meso substituents 
allowed the anchoring of the desired number (one or four) of 
carbohydrate units onto the porphyrin skeleton by a nucleophilic 
substitution of the para fluorine atom of the C6F5 moiety.  
On the other hand, the C2-symmetrical tetra-carbohydrate 
porphyrin 7 was obtained by following the procedure reported in 
Scheme 3. Porphyrin 4[11] was used as the starting material to 
take advantage of its pre-organised symmetry, which plays an 
important role in determining the reaction diasteroselectivity (this 
aspect will be further discussed in the catalytic section).  
 
Scheme 3. Synthesis of C2-symmetrical porphyrin 7.  
The reaction of benzyl chloride pickets of porphyrin 4 with NaN3 
forms, in 95% yield, the corresponding azido derivative 5, which 
yields Zn(5) in a quantitative yield by reacting with 
Zn(OAc)2 2H2O. Then, the “click” reaction of Zn(5) with glucoside 
6,[12] which was prepared by reacting the corresponding methyl 
2,3,6-tri-O-benzyl--D-glucopyranoside with propargyl bromide 
in the presence of sodium hydride, yielded Zn(7). Finally, the 
free base porphyrin 7 was obtained by removing the Zn atom 
with HCl 37%. Although the synthetic procedure to obtain 7 
requires four steps, three of them occurred in quantitative yields 
and one with a yield up to 63%. The synthesis of 7 was 
performed at low temperatures (under 50°C) to avoid the 
formation of the statistical distribution of atropoisomers.[11, 13] 
The so-obtained porphyrins 2, 3 and 7, as well as their 
precursors F5TPPH2 and F20TPPH2, were employed to 
synthesise corresponding iron and ruthenium complexes 
(Figure 1) to be tested as catalysts of cyclopropanation and 
aziridination reactions. Importantly, the catalytic activity of iron 
and ruthenium derivatives of F5TPPH2 and F20TPPH2 porphyrins 
was investigated to better evaluate the influence of 
carbohydrates on the catalytic performances. 
 
Figure 1. Ruthenium and iron glycosylated porphyrin complexes. 
All Fe(porphyrin)OMe complexes were easily obtained by 
refluxing the desired porphyrin ligand with an excess of FeBr2 in 
anhydrous THF for 5 hours. As previously reported,[14] the 
oxidation of the initially formed Fe(II) species by atmospheric 
oxygen was responsible for the formation of Fe(III) complexes. 
The anchorage of the methoxy axial ligand to the metal occurred 
both during the MeOH-based chromatography purification and 
the final treatment of the complexes with MeOH at 50°C. All 
synthesised Fe(porphyrin)OMe complexes were characterised 
by elemental analysis, UV/VIS and MS spectroscopy (see 
experimental section). 
The insertion of ruthenium into porphyrin rings generally requires 
experimental conditions more drastic than those employed for 
the iron insertion. Indeed, Ru(F5TPP)CO, Ru(F20TPP)CO and 
Ru(2)CO were obtained by refluxing the corresponding ligand 
with an excess of Ru3(CO)12 in 1,2,3-trichlorobenzene as the 
reaction solvent. Considering that Ru(3)CO was not obtained by 
simply treating Ru3(CO)12 with ligand 3, an alternative strategy 
was applied. Complex Ru(F20TPP)CO was first synthesised and 
then reacted with 1 in the presence of sodium hydride to yield 
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Ru(3)CO in 39% yield. Unfortunately, all the above described 
procedures failed for the insertion of ruthenium into porphyrin 7. 
Thus, Ru(7)CO complex was obtained in 19% yield by reacting 
porphyrin 7 with Ru3(CO)12 in a pressure tube at 150°C, using 
toluene as the reaction solvent. The low yield in which Ru(7)CO 
was obtained can be due to the high working temperature 
(150°C) which, by promoting the ligand atropoisomerization, 
may be responsible for the formation of the desired ruthenium 
complex in a limited amount. 
The activity of all the synthesised iron and ruthenium complexes 
was initially tested in the model cyclopropanation reaction 
between methylstyrene and ethyl diazoacetate (EDA) forming 
8, and the achieved results are shown in Table 1. 
 
 
Table 1. Synthesis of 8 catalysed by iron(III) and ruthenium(II) 
glycoporphyrin complexes.
[a]
 
 
entry catalyst yield (%)
[b]
 trans/cis
[b]
 
1 Fe(F5TPP)(OMe) 80 87:13 
2 Fe(2)(OMe) 80 88:12 
3 Ru(F5TPP)(CO) 70 88:12 
4 Ru(2)(CO) 68 90:10 
5 Fe(F20TPP)(OMe) 60 60:40 
6 Fe(3)(OMe) 71 80:20 
7 Ru(F20TPP)(CO) 45 60:40 
8 Ru(3)(CO) 61 78:22 
9 Fe(7)(OMe) 69 95:5 
10 Ru(7)(CO) 66 95:5 
[a] Reactions were stirred in toluene for 2 h at 25°C by using 
catalyst/EDA/-methylstyrene = 1:1100:5000. [b] Determined by 
1
H NMR 
spectroscopy using 2,4-dinitrotoluene as the internal standard. 
The conjugation of F5TPPH2 with one saccaride unit (1) forming 
porphyrin 2 was not responsible for an enhancement of the 
catalytic performances of corresponding iron and ruthenium 
derivatives. In fact, analogous results, both in terms of yields 
and diastereoselectivities, were obtained (compare entries 1 and 
3 with 2 and 4, Table 1). On the other hand, both Fe(3)(OMe) 
and Ru(3)(CO) were more productive than their parent 
Fe(F20TPP)(OMe) and Ru(F20TPP)CO compounds to indicate a 
positive effect of the insertion of four carbohydrate units onto the 
porphyrin skeleton. A better diastereocontrol was also observed 
(compare entries 5 and 7 with 6 and 8, Table 1). Finally, even if 
cyclopropanes 8 (cis + trans) were obtained with lower yields by 
using Fe(7)(OMe) and Ru(7)(CO), these two catalysts were 
responsible for the best reaction diastereoselectivities (Table 1, 
entries 9 and 10). 
Note that porphyrins 3 and 7 contain the same number of 
carbohydrate units, which are respectively located in para 
position of the meso aromatic moiety in ligand 3 and on the 
pickets of the C2 symmetrical skeleton of 7. While the different 
location of the four carbohydrate units did not influence the 
reaction yields, the position of the carbohydrate moiety had a 
relevant effect on the reaction diastereoselectivity. In 
accordance with our previous studies,[14b] the C2-symmetry of the 
porphyrinic skeleton of 7 was responsible for the highest 
diastereocontrol, independently of the nature of the active metal 
(compare entries 9 and 10 with entries 6 and 8, Table 1). It is 
important to point out that, while the nature of the final chiral 
pickets was not crucial for determining the 
trans-diastereoselectivity, their electronic and steric features 
were responsible for the enantioselective induction.[14] In fact, 
even though similar diastereoselectivities were observed in the 
presence of a porphyrin catalyst obtained by functionalizing the 
22 parent porphyrin 4 (Scheme 3) with either binaphthyl
[14b] or 
amino acid chiral units,[14c] the reaction enantioselectivity was 
very different in the two cases.  
Unfortunately, none of the complexes reported in Table 1 
induced an enantiocontrol, probably due to the long distance 
between the chiral carbohydrates and the active metal centre.  
Although the efficiency of glycoporphyrin complexes was 
comparable to those of their precursors, the catalytic activity of 
glycoporphyrin complexes has been further investigated in view 
of the excellent diastero discriminations achieved a high 
potential of these catalytic systems. 
In fact, the presence of saccharides in the ligand skeleton will be 
exploited to perform catalytic reactions in a biphasic medium, 
after deprotection of the carbohydrate moieties. 
Complex Fe(2)OMe was selected as the most convenient 
catalyst to study the reaction scope in view of i) the catalytic 
results of Table 1, ii) the importance of using eco-compatible 
non-noble metal catalysts and iii) the easier synthetic 
accessibility of porphyrin 2 with respect to ligands 3 and 7, which 
facilitates to obtain corresponding metal catalysts in significant 
amounts for affordable applications of the methodology. 
Obtained results are reported in Table 2.  
Catalytic tests were performed by using either the molar ratio 
Fe(2)OMe/EDA/alkene = 1:1100:5000, or a slight EDA excess 
with respect to the alkene substrate (Fe(2)OMe/EDA/alkene = 
1:1100:1000). Reported data indicated that an alkene excess 
was necessary for suppressing the EDA homo-coupling process, 
which in turn decreases the cyclopropane yields. The catalytic 
productivity was influenced by the steric hindrance of the 
aromatic portion of the employed alkene, as proven by the lower 
yield that was observed by using 2-methylstyrene instead of 
3-methylstyrene or 4-methylstyrene, as the reaction substrate 
(products 10, 11 and 12). The best yields were achieved by 
using para-substituted -methylstyrene, independently of the 
electronic nature of the alkene substituent (products 8, 14 and 
15). Very good trans-diastereoselectivities, up to 92:8, were 
obtained for all the tested catalytic reactions.  
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Table 2. Synthesis of cyclopropanes 8-15 catalysed by Fe(2)(OMe).
[a] 
 
 
[a] Reactions were stirred in toluene for 2 h at 25°C by using 
Fe(2)(OMe)/EDA/alkene = 1:1100:5000. [b] Determined by 
1
H NMR 
spectroscopy using 2,4-dinitrotoluene as the internal standard. 
[c] Fe(2)(OMe)/EDA/alkene = 1:1100:1000. 
Next, styrene and -methylstyrene were reacted, in the 
presence of Fe(2)OMe, with diazo derivatives showing different 
steric hindrances and electronic features by using experimental 
conditions reported in Table 2. While the only-acceptor 
(COOtBu)CHN2 compound reacted with styrene affording the 
corresponding cyclopropane 16 in 48% yield and a trans/cis ratio 
of 88:12 (see SI), the analogous reaction with the more sterically 
encumbered -methylstyrene did not yield the desired 
cyclopropane. Unfortunately, the reaction of acceptor-acceptor 
and donor-acceptor substituted diazo compounds with either 
styrene or -methylstyrene did not occur (Scheme 4). 
 
Scheme 4. Reactivity of diazo reagents in the Fe(2)OMe-catalysed 
cyclopropanation of styrene (R = H) and -methylstyrene (R = Me).  
Then, the catalytic activity of iron and ruthenium glycoporphyrin 
complexes as well as their precursors, was tested in the 
aziridination of -methylstyrene by 3,5-bis(trifluoromethyl)phenyl 
azide, forming 17. No aziridine was formed by using 
Fe(F5TPP)(OMe), Fe(2)(OMe), Fe(3)(OMe) and Fe(7)(OMe) 
while, Fe(F20TPP)(OMe) led to the formation of 17 in 90% yield. 
This result was in accordance with literature, which reports good 
activities for the F20TPP-containing iron catalysts.
[15] 
 
Table 3. Synthesis of 17 catalysed by ruthenium complexes.
[a]
 
 
entry catalyst yield (%)
[b]
 
1 Ru(F5TPP)(CO) 81 
2 Ru(F20TPP)(CO) 83 
3 Ru(2)CO 80 
4 Ru(3)CO 17 
5 Ru(7)CO  - 
[a] Reactions were refluxed for 2 h in benzene by using 
catalyst/azide/-methylstyrene = 1:50:250. [b] Determined by 
1
H NMR 
spectroscopy using 2,4-dinitrotoluene as the internal standard. 
On the other hand, while Ru(3)CO complex showed a limited 
catalytic efficiency (Table 3, entry 4), Ru(F5TPP)(CO), 
Ru(F20TPP)(CO) and Ru(2)CO mediated the synthesis of 17 in 
analogous yields (Table 3, entries 1, 2 and 3). Finally, Ru(7)CO 
was inactive in promoting the model reaction forming 17 (Table 
3, entry 5) probably due to the tridimensional arrangement of the 
ligand, which hampered a productive interaction of substrates 
with the active ruthenium metal centre. 
Considering what stated above on the prospective employment 
of glycoporphyrin catalysts and the good result that was 
obtained by performing the synthesis of 17 in the presence of 
Ru(2)CO, this complex was used to study the reactivity of 
-methylstyrene towards different aryl azides. Achieved results 
are reported in Table 4. 
 
Table 4. Synthesis of aziridines catalysed by Ru(2)(CO).
[a]
 
 
 
[a] Reactions were refluxed in benzene for 2 h by using 
Ru(2)(CO)/azide/-methylstyrene = 1:50:250. [b] Determined by 
1
H NMR 
spectroscopy using 2,4-dinitrotoluene as the internal standard. 
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Collected data indicate that the electronic nature of the aromatic 
azide seems not to strongly influence the Ru(2)CO catalytic 
performance. Indeed, comparable yields were obtained by using 
either 4-(NO2)C6H4N3 (Table 4, compound 20) or 4-(
tBu)C6H4N3 
(Table 4, compound 21) azide. Very good aziridine yields were 
also observed by employing both ortho and meta-substituted 
(with respect the N3 functionality) azides to indicate that the 
aziridine formation was slightly hampered by the presence of 
substituents close the reactive N3 grouping (Table 4, compounds 
17, 18 and 19). 
Low yields were obtained by using azides bearing on the aryl 
moiety a coordinating substituent such as a methoxy group 
(Table 4, compounds 22 and 23), which can be responsible for a 
catalytic deactivation by competing with the organic substrate for 
the metal centre. In accordance with that already reported by 
some of us,[16] the negative effect was more pronounced 
reacting -methystyrene with 4-(MeO)C6H4N3 than 
3,4,5-(MeO)3C6H2N3 due to the better coordinating capability of 
an unhindered methoxy group compared to three contiguous 
ones (compare yields of products 22 and 23). 
Conclusions 
In conclusion, we reported the synthesis and catalytic activity of 
three different iron and ruthenium glycoporphyrins and their 
related precursors. While iron(III) derivatives showed good 
performances in alkene cyclopropanations, ruthenium(II) 
complexes were efficient promoters of aziridination reactions. 
Among all synthesised catalysts, the catalytic activity of 
Fe(2)(OMe) and Ru(2)CO was further investigated because 
porphyrin 2 can be considered a valuable ligand being easily 
synthesised in good yields and the amphiphilic nature of 2 can 
be well suitable, after deprotection of the carbohydrate residue, 
to perform catalysis in a biphasic medium due to the presence of 
the hydrophilic carbohydrate and the lipophilic tetrapyrrolic core. 
In addition, the present work can pave the way to other 
investigations because the synthesis of 2 can be applied to 
anchor a polysaccharides to F5TPPH2. This synthetic strategy 
could be useful to incorporate low-toxic metal catalyst (e.g. iron 
derivatives) into a biologic scaffold in order to provide 
sustainable catalysts to be tested for eco-compatible catalytic 
applications in an aqueous medium.  
Experimental Section 
General Conditions. All catalytic reactions and some of the synthetic 
procedures reported (where specified) were carried out under nitrogen 
atmosphere employing standard Schlenk techniques and vacuum-line 
manipulations. All the solvents were dried by using standard procedures 
unless otherwise specified.  
Reagents. Organic azides,[17] diazo compounds,[18] meso-
tetrakis(pentafluorophenyl)porphyrin (F20TPPH2),
[10] 
5-(pentafluorophenyl)-10,15,20-triphenylporphyrin (F5TPPH2),
[9] methyl 
2,3,6-tri-O-benzyl-4-O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)--D-
glucopyranoside (1),[8] -5,10-β-15,20-tetrakis(2-[(3-
chloromethyl)benzoylamido]phenyl) porphyrin (5),[11] methyl 2,3,6-tri-O-
benzyl-4-O-(prop-2-ynyl)--D-glucopyranoside (6),[12] 
Ru(F20TPP)(CO)
[19] were synthesised as reported in literature. Other 
starting materials have been purchased and used as received. 
Instruments. NMR spectra were recorded at room temperature either on 
a Bruker Avance 300-DRX, operating at 300 MHz for 1H, at 75 MHz for 
13C and at 282 MHz for 19F, or on a Bruker Avance 400-DRX 
spectrometers, operating at 400 MHz for 1H, 100 MHz for 13C and 376 
MHz for 19F. Chemical shifts (ppm) are reported relative to TMS. The 1H 
NMR signals of the compounds described in the following were attributed 
by 2D NMR techniques. Assignments of the resonance in 13C NMR were 
made by using the APT pulse sequence, HSQC and HMBC techniques. 
Infrared spectra were recorded on a Varian Scimitar FTS 1000 
spectrophotometer. UV/Vis spectra were recorded on an Agilent 8453E 
instrument. MALDI-TOF spectra were acquired either on a Bruker 
Daltonics Microflex or on a Bruker Daltonics Autoflex III TOF/TOF at 
C.I.G.A, University of Milan. High resolution MS (HR-MS) spectra were 
obtained on a Bruker Daltonics ICR-FTMS APEX II at C.I.G.A, University 
of Milan. Microanalysis was performed on a Perkin Elmer 2400 CHN 
Elemental Analyzer instrument. 
Synthesis of 2. NaH 60% (128.0 mg, 5.32 mmol) was added under 
nitrogen to a toluene (28.0 mL) solution of F5TPPH2 (150.0 mg, 2.13 x 
10-1 mmol) and 1 (380.0 mg, 4.33 x 10–1 mmol). The resulting solution 
was refluxed for 50 h until the complete consumption of the starting 
porphyrin observed by TLC (SiO2, n-hexane/AcOEt = 7:3). Residual NaH 
was quenched with HCl 1.0 N and CH2Cl2 (50.0 mL) was added to the 
mixture. The organic phase was extracted with H2O until pH = 7, then 
dried over Na2SO4 and filtered. The solvent was evaporated to dryness 
under vacuum and the residue purified by flash chromatography (SiO2, 
gradient elution from n-hexane to n-hexane/AcOEt = 7:3) to yield a purple 
solid 2 (135.0 mg, 60%). 1H NMR (300 MHz, CDCl3): δ 8.90 (s, 4H, 
Hβpyrr ), 8.84 (d, J = 5.4 Hz, 2H, Hβpyrr ), 8.51 (d, J = 4.8 Hz, 2H, Hβpyrr), 
8.26 (t, J = 6.3 Hz, 6H, HAr ), 7.89 – 7.73 (m, 9H, HAr), 7.45 - 7.19 (m, 
46H, HAr + Hsolvent), 5.15 (dd, J = 13.4, 11.2 Hz, 2H, Hsugar), 5.03 – 4.73 
(m, 12H, Hsugar), 4.73 – 4.60 (m, 2H Hsugar), 4.36 (dd, J = 17.7, 7.6 Hz, 
2H, Hsugar), 4.20 (t, J = 9.3 Hz, 1H, Hsugar), 4.12 (dd, J = 11.4, 1.9 Hz, 1H, 
Hsugar), 4.06 – 3.86 (m, 3H, Hsugar), 3.85 – 3.74 (m, 3H, Hsugar), 3.73 – 
3.56 (m, 7H, Hsugar), 3.54 - 3.27 (m, 4H, Hsugar),  -2.73 (s, 2H, NHpyrr). 
19F 
NMR (282 MHz, CDCl3): δ -139.36 (dd, J = 24.5, 8.1 Hz, 2F), -156.83 
(dd, J = 23.7, 8.7 Hz, 2F). 13C NMR (75 MHz, CDCl3): δ 142.38, 142.22, 
139.58, 139.05, 138.63, 138.52, 135.01, 134.93, 129.05, 128.98, 128.85, 
128.82, 128.78, 128.72, 128.70, 128.65, 128.56, 128.52, 128.48, 128.43, 
128.40, 128.37, 128.28, 128.23, 128.19, 128.17, 128.13, 128.08, 128.04, 
128.00, 127.95, 127.80, 127.76, 127.70, 127.62, 127.51, 127.16, 127.10, 
105.18, 105.08, 102.79, 102.53, 85.23, 84.73, 84.36, 84.10, 83.34, 
83.14, 83.07, 82.44, 82.18, 82.11, 81.13, 76.84, 75.43, 75.29, 74.86, 
74.38, 73.32, 71.98, 71.51, 57.56, 57.49, 57.44. IR νmax (CH2Cl2)/cm
-1: 
1089, 1200, 1362, 1497, 1453, 1430, 1712, 1989, 3063. UV-Vis: λmax 
(CH2Cl2)/nm (log ε): 418 (4.7), 513 (3.6), 548 (3.2), 588 (3.1), 645 (3.1).  
LR-MS (ESI): m/z (C99H85F4N4O11) calcd. 1582.77; found [M+H]
+ 1583.6. 
Elemental analysis calc. for C99H85F4N4O11 C, 75.13; H, 5.41; N, 3.54; 
found: C, 75.35; H, 5.70; N, 3.45.  
Synthesis of 3. NaH 60% (123.0 mg, 3.08 mmol) was added under 
nitrogen to a toluene (9.0 mL) solution of F20TPPH2 (50.0 mg, 5.13 x 10
–2 
mmol) and 1 (368.0 mg, 4.15 x 10–1 mmol). The resulting solution was 
refluxed for 50 h until the complete consumption of the starting porphyrin 
observed by TLC (SiO2, n-hexane/AcOEt = 7:3). Residual NaH was 
quenched with HCl 1.0 N and CH2Cl2 (15.0 mL) was added to the 
mixture. The organic phase was extracted with H2O until pH = 7, then 
dried over Na2SO4 and filtered. The solvent was evaporated to dryness 
under vacuum and the residue purified by flash chromatography (SiO2, 
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gradient elution from n-hexane to n-hexane/AcOEt = 7:3) to yield a purple 
solid 3 (95.0 mg, 40%). 1H NMR (400 MHz, CDCl3): δ 8.44 (s, 8H, Hβpyrr), 
7.46 (m, 30H, HAr), 7.39 – 7.19 (m, 109H, HAr + Hsolvent), 7.13 (t, J = 7.2 
Hz, 4H, HAr), 5.13 (dd, J = 16.0, 11.4 Hz, 8H, Hsugar), 4.95 – 4.75 (m, 34H, 
Hsugar), 4.66 (dd, J = 22.7, 9.9 Hz, 9H, Hsugar), 4.52 (d, J = 12.1 Hz, 8H, 
Hsugar), 4.36 (d, J = 7.6 Hz, 4H, Hsugar), 4.20 – 4.11 (m, 8H, Hsugar), 4.01 – 
3.56 (m, 43H, Hsugar), 3.52 – 3.39 (m, 8H, Hsugar),- 3.02 (s, 2H, NHpyrr).  
19F NMR (376 MHz, CDCl3): δ -138.80 – -138.87 (m, 8F), -156.04 (d, J = 
17.2 Hz, 8F). 13C NMR (100 MHz, CDCl3): δ 147.74, 145.35, 141.87, 
141.70, 139.39, 139.23, 138.70, 138.59, 138.49, 138.19, 138.13, 128.66, 
128.57, 128.46, 128.34, 128.31, 128.12, 128.08, 128.03, 127.88, 127.82, 
127.78, 127.57, 127.45, 127.42, 127.39, 127.33, 113.88, 113.69, 113.50, 
104.84, 104.03, 102.16, 83.80, 83.01, 82.71, 81.78, 80.99, 76.72, 76.46, 
75.36, 75.24, 75.02, 74.96, 74.93, 74.52, 73.71, 73.61, 69.49, 68.07, 
57.13. IR νmax (CH2Cl2)/cm
-1: 1004, 1060, 1209, 1361, 1399, 1432, 1497, 
2626, 2870, 2926, 3061. UV-Vis: λmax (CH2Cl2)/nm (log ε): 416 (5.9), 509 
(4.2), 538 (4.4), 584 (3.7.), 639 (2.8). LR-MS (MALDI): m/z 
(C264H248F16N4O44) calcd. 4481.70; found [M] 4481.3. Elemental analysis 
calc. for (C264H248F16N4O44) C, 70.73; H, 5.53; N, 1.25; found: C, 70.84; 
H, 5.66; N, 1.24. 
Synthesis of 5. Sodium azide (28.0 mg, 4.31 mmol) was added to a 
DMF (10.0 mL) solution of porphyrin 4 (100.0 mg, 7.71 x 10-2 mmol). The 
resulting solution was stirred at 85 °C for 3 hours until the complete 
consumption of the porphyrin 4 was observed by TLC (SiO2, 
CH2Cl2/MeOH = 99:1), then distilled water (30.0 mL) was added and the 
mixture was extracted with CH2Cl2 (3 x 50.0 mL). The organic phase was 
washed with a saturated solution of NH4Cl (3 x 50.0 mL), dried over 
Na2SO4 and filtered. The solvent was evaporated to dryness under 
vacuum and the residue purified by flash chromatography (SiO2, gradient 
elution from CH2Cl2 to CH2Cl2/MeOH = 95:5) to yield a purple solid 5 
(150.0 mg, 95%). 1H NMR (400 MHz, CDCl3): δ 8.98 – 8.82 (m, 11H, 
Hβpyrr + HAr), 8.04 - 7.88 (m, 9H, HAr), 7.70 – 7.45 (m, 8H, HAr), 6.76 – 
6.18 (m, 16H, HAr), 3.35 – 3.06 (m, 8H, HCH2-N3), -2.49 (s, 2H, NHpyrr). 
13C 
NMR (100 MHz, CDCl3, 298 K): δ 165.30, 157.39, 138.98, 135.76, 
135.63, 135.53, 135.37, 135.08, 130.70, 128.81, 128.56, 126.57, 126.44, 
126.16, 126.04, 123.92, 115.54, 53.76, 53.64, 53.55, 53.47. IR νmax 
(CH2Cl2)/cm
-1: 1091, 1222, 1362, 1428, 1712, 2100, 2962, 3004, 3061, 
3407. UV-Vis λmax (CH2Cl2)/nm (log ε): 421 (4.7), 483 (3.3), 517 (3.8), 
548 (3.4), 592 (3.4), 647 (3.2). LR-MS (ESI): m/z (C76H54N20O4) calcd. 
1311.37; found [M+H]+ 1312.4. Elemental analysis calc. for C76H54N20O4: 
C, 69.61; H, 4.15; N, 21.36; found: C, 69.72; H, 4.15; N, 21.36. 
Synthesis of Zn(5). A solution of Zn(OAc)2∙2H2O (375.0 mg, 1.71 mmol) 
in MeOH (8.0 mL) was added to a CH2Cl2 (60.0 mL) solution of 5 (150.0 
mg, 1.14 x 10–1 mmol). The resulting solution was stirred overnight at 
room temperature until the complete consumption of 5 was observed by 
TLC (SiO2, CH2Cl2/MeOH = 99:1), then H2O (50.0 mL) was added to the 
mixture. The organic phase was extracted with H2O (3 x 50.0 mL), dried 
over Na2SO4 and filtered. The solvent was evaporated to dryness under 
vacuum to give the purple compound Zn(5) (155.0 mg, 99%). 1H NMR 
(400 MHz, CDCl3, 298 K): δ 9.04 – 8.96 (m, 8H, Hβpyrr), 8.82 - 8.72 (m, 
4H, HAr), 8.11 – 8.09 (m, 1H, HAr), 8.05 (d, J = 7.4 Hz, 1H, HAr), 8.02 – 
7.96 (m, 2H, HAr), 7.91 – 7.84 (m, 5H, HAr), 7.68 (s, 1H, HNH), 7.61 – 7.52 
(m, 5H, HAr + HNH), 7.47 (s, 1H, HNH), 7.30 (s, 1H, HNH), 6.75 (d, J = 7.5 
Hz, 1H, HAr), 6.62 – 6.57 (m, 3H HAr), 6.50 – 6.39 (m, 4H, HAr), 6.38 – 
6.29 (m, 4H, HAr), 6.01 – 5.94 (m, 2H, HAr), 5.66 – 5.61 (m, 2H, HAr), 2.97 
(s, 1H, HCH2-N3), 2.81 (m, 2H, HCH2-N3), 2.65 (d, J = 13.8, 1H, HCH2-N3), 
2.55 (m, 3H, HCH2-N3), 2.12 (s, 1H, HCH2-N3). 
13C NMR (300 MHz, CDCl3, 
298 K): δ 164.75, 152.00, 151.26, 150.78, 138.75, 132.88, 130.28, 
123.39, 126.36, 123.58, 121.08, 115.88, 52.82, 52.69, 52.38. IR νmax 
(CH2Cl2)/cm
-1: 996, 1250, 1308, 1447, 1518, 1581, 1681, 2101, 2340, 
2360, 3415. UV-Vis λmax (CH2Cl2)/nm (log ε): 425 (5.58), 556 (4.30), 592 
(1.20), 626 (2.78) (1.20). LR-MS (ESI): m/z (C76H52N20O4Zn) calcd. 
1372.38; found [M+Na]+ 1396.4. Elemental Analysis calc. for 
C76H54N20O4Zn: C, 66.30; H, 3.95, N, 20.35; found: C, 66, 54; H, 3.99; N, 
20.16. 
Synthesis of Zn(7). Zn(5) (150.0 mg, 1.11 x 10–1 mmol) and 6 (276.0 
mg, 5.54 x 10–1 mmol) were dissolved in THF (20.0 mL) and then a 
solution of CuSO4∙5H2O (137.0 mg, 5.54 x 10
–1mmol) in H2O (5.0 mL) 
was added. A solution of sodium ascorbate (109.0 mg, 5.54 x 10–1 mmol) 
in H2O (5 mL) was added and the resulting mixture was stirred for 5 
hours at 50°C until the complete consumption of Zn(5) was observed by 
TLC (SiO2, CH2Cl2/MeOH = 97:3). The mixture was extracted with 
CH2Cl2 (3 x 20.0 mL), dried over Na2SO4 and filtered. The solvent was 
evaporated to dryness under vacuum and the residue purified by flash 
chromatography (SiO2, gradient elution from CH2Cl2 to CH2Cl2/MeOH 
98:2) to yield the purple solid 7 (232.0 mg, 63%). 1H NMR (400 MHz, 
CDCl3, 298 K): δ 8.98 - 8.75 (m, 12 H, Hβpyrr + HAr), 8.09 (t, J = 6.6 Hz, 
4H, HAr),7.85 – 7.81 (m, 8H, HAr + HNH), 7.75 (s, 1H, HNH), 7.61 (s, 1H, 
HNH), 7.52 – 6.94 (m, 88H, HAr + Hsolvent), 6.82 – 6.74 (m, 4H, HAr), 6.66 – 
6.47 (m, 12H, HAr), 6.26 – 6.18 (m, 3H, HAr), 5.84 – 5.72 (m, 4H, HCH2), 
5.52 – 5.48 (m, 2H, HCH2), 5.41 – 5.34 (m, 2H, HCH2), 5.01 – 4.92 (m, 1H, 
Hsugar), 4.84 (d, J = 11.2 Hz, 2H, Hsugar), 4.72 (q, J = 9.5, 7.8 Hz, 6H, 
Hsugar), 4.66 – 4.52 (m, 9H, Hsugar), 4.49 – 4.24 (m, 12H, Hsugar), 4.22 – 
4.14 (m, 2H, Hsugar), 4.05 – 3.97 (m, 2H, Hsugar), 3.78 (t, J = 9.2 Hz, 2H, 
Hsugar), 3.69 – 3.62 (m, 1H, Hsugar), 3.57 – 3.39 (m, 8H, Hsugar), 3.31 – 
3.29 (m, 12H, Hsugar), 3.23 – 3.13 (m, 1H, Hsugar), 3.04 (d, J = 11.6 Hz, 
1H, Hsugar), 2.93 (t, J = 9.4 Hz, 1H, Hsugar). 
13C NMR (100 MHz, CDCl3, 
298 K): δ 139.42, 139.10, 138.41, 128.86, 128.68, 128.50, 128.34, 
128.05, 127.89, 119.49, 99.34, 98.47, 82.28, 81,98, 81.42, 80.17, 73.75, 
70.67, 70.15, 68.77, 65.58, 65.45, 63.73, 55.99, 52.76. IR νmax 
(CH2Cl2)/cm
-1: 1047, 1091, 1223, 1273, 1362, 1446, 1519, 1582, 1712, 
2928, 3060, 3411. UV λmax (CH2Cl2)/nm (log ε): 434 (5.20), 563 (4.08), 
602 (3.51). HR-MS (MALDI): m/z (C200H188N20O28Zn) calcd. 3383.33, 
found [M] 3383.6. Elemental Analysis calc. for  C200H188N20O28Zn : C, 
70.96; H, 5.60; N, 8.28; found: C, 71.06; H, 5.70; N, 8.20. 
Synthesis of 7. HCl 37% (30.0 mL) was added to a AcOEt (120.0 mL) 
solution of Zn(7) (200.0 mg, 5.92 x 10–2 mmol). The resulting solution 
was stirred for 3 hours at room temperature until the complete 
consumption of Zn(7) was observed by TLC (SiO2, CH2Cl2/MeOH = 
97:3), then H2O (100.0 mL) was added to the mixture. The organic phase 
was extracted with H2O (3 x 100.0 mL) until pH = 7. The resulting 
solution was dried over Na2SO4 and filtered. The solvent was evaporated 
to dryness under vacuum to yield the purple solid 7 (195.0 mg, 99%). 1H 
NMR (400 MHz, CDCl3, 298 K): δ 8.91 - 8.82 (m, 8H, Hβpyrr), 8.77 – 8.59 
(m, 4H, HAr), 7.93 – 7.83 (m, 9H, HAr), 7.72 (s, 2H, Htriazo), 7.51 – 7.48 (m, 
5H, HAr + Htriazo), 7.31 – 7.07 (m, 63H, HAr + Hsolvent), 6.89 – 5.86 (m, 19H, 
HAr), 4.91 – 4.26 (m, 46H, Hsugar), 3.85 – 3.79 (t, J = 9.2 Hz, 4H, Hsugar), 
3.59 –3.49 (m, 20H, Hsugar), 3.33 (s, 12H, HOMe), -2.64 (s, 2H, NHpyrr). 
13C 
NMR (100 MHz, CDCl3, 298 K): δ 165.14, 145.69, 145.57, 139.16, 
138.73, 138.54, 138.67, 138.45, 138.38, 138.35, 135.89, 135.55, 135.49, 
135.35, 135.20, 130.91, 130.67, 130.60, 128.86, 128.78, 128.75, 128.70, 
128.64, 128.52, 128.33, 128.25, 128.20, 128.13, 128.07, 127.95, 127.90, 
127.85, 127.79, 127.74, 127.33, 126.97, 126.04,125.56, 124.21, 122.85, 
122.48, 115.88, 115.62, 98.52, 82.22, 82.18, 80.18, 78.13, 78.07, 75.87, 
73.75, 70.24, 68.78, 66.26, 55.60, 52.82. IR νmax (CH2Cl2)/cm
-1: 1047, 
1096, 1266, 1306, 1449, 1518, 1582, 1680, 2929, 2960, 3033, 3417. UV-
Vis λmax (CH2Cl2)/nm (log ε): 424 (5.50), 521 (4.24), 549 (3.70), 591 
(3.76), 647 (3.51). HR-MS (MALDI): m/z (C200H190N20O28) calcd. 3321.41, 
found [M+Na]+ 3344.3. Elemental analysis calc. for C200H190N20O28: C, 
72.32; H, 5.77; N, 8.43; found: C, 72.01; H, 5.88; N, 8.31.  
General procedure for the synthesis of iron(III) complexes. FeBr2 
(1.42 mmol) was added to a THF (20.0 mL) solution of porphyrin (7.12 x 
10–2 mmol) under nitrogen. The solution was refluxed at 75oC for 5 hours 
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until the complete consumption of the starting porphyrin observed by TLC 
(Al2O3, CH2Cl2/MeOH = 97:3). The solvent was evaporated to dryness 
under vacuum and the residue purified by chromatography (Al2O3, eluent 
CH2Cl2/MeOH 97:3) to yield a brown solid corresponding to the iron 
complex. Finally, all the iron complexes were treated at 50°C with MeOH 
for 8 h. The solvent was evaporated to dryness to afford the desired 
compound. 
Fe(F5TPP)(OMe) 92% yield. IR νmax (CH2Cl2)/cm
-1: 1091, 1277, 1273, 
1420, 2854, 2927, 3054, 3059. UV-Vis λmax (MeOH)/nm (log ε): 413 (3.7), 
478 (2.8), 484 (2.8). LR-MS (ESI): m/z (C45H26F5FeN4O) calcd. 789.14; 
found [M-OMe] 759.18. Elemental analysis calc. for C45H26FeN4O: calcd. 
C, 68.45; H, 3.32; N, 7.10; found C, 68.67; H, 3.63; 6.96. 
Fe(2)(OMe) 90% yield. IR νmax (CH2Cl2)/cm
-1: 1026, 1092, 1271, 1280, 
1422, 2927, 2961, 3056. UV-Vis λmax (MeOH)/nm (log ε): 413 nm (5.7), 
495 (3.6), 600 (3.4). LR-MS (ESI) m/z: (C100H85F4FeN4O12) calcd. 
1665.54, found [M+Na]+ 1688.59. Elemental analysis calc. for 
C100H85F4FeN4O12 C 72.07, H 5.14, N 3.36; found: C, 72.25; H, 5.35; N, 
3.30.  
Fe(3)(OMe) 95% yield. IR νmax (CH2Cl2)/cm
-1: 1081, 1259, 1266, 1278, 
2857, 2926, 3058. UV-Vis λmax (MeOH)/nm (log ε): 410 (5.1), 519 (3.8), 
580 (3.7). HR-MS (MALDI): m/z (C265H249F16FeN4O45) calcd. 4566.64, 
found [M-OMe+Na]+ 4559.2. Elemental analysis calc. for 
C265H249F16FeN4O45 C, 69.65; H, 5.49; N, 1.23; found: C, 69.83; H, 5.62, 
N, 1.21.  
Fe(7)(OMe) 92% yield. IR νmax (CH2Cl2)/cm
-1: 1447, 1452, 1512, 1582, 
1680, 2867, 2928, 2960, 3417. UV-Vis λmax (CH2Cl2)/nm (log ε) 421 
(5.43), 478 (4.78), 581 (4.39). HR-MS (MALDI): m/z (C201H191FeN20O28) 
calcd. 3406.35, found [M-OMe] 3375.0. Elemental analysis calc. for 
C201H191FeN20O28: C 70.87, H 5.65, N 8.22; found C 70.97, H 5.75, N 
8.15. 
Synthesis of Ru(F5TPP)(CO) and Ru(2)(CO). Ru3CO12 (2.13 x 10
–1 
mmol) was added to a 1,2,4-trichlorobenzene (20.0 mL) solution of 
porphyrin (7.12 x 10–2 mmol) under nitrogen. The solution was refluxed 
for 5 hours until the complete consumption of the starting porphyrin was 
observed by TLC (SiO2, n-hexane/AcOEt = 7:3). The solvent was 
evaporated to dryness under vacuum and the residue purified by 
chromatography (SiO2, gradient elution from n-hexane to n-
hexane/AcOEt = 7:3) to yield a red solid corresponding to the ruthenium 
complex. 
Ru(F5TPP)(CO) 68% yield. 
1H NMR (300 MHz, CDCl3): δ 8.78 (d, J = 4.9 
Hz, 2H, Hβpyrr), 8.69 (s, 4H, Hβpyrr), 8.61 (d, J = 4.9 Hz, 2H, Hβpyrr), 8.25 – 
8.09 (m, 6H, HAr), 7.82 – 7.67 (m, 9H, HAr). 
19F NMR (282 MHz, CDCl3): δ 
-136.62 (dd, J = 24.2, 9.0 Hz, 1F), -138.24 (d, J = 24.3 Hz, 1F), -153.73 
(t, J = 21.0 Hz, 1F), -162.48 (t, J = 23.4 Hz, 1F), -163.06 (d, J = 23.9 Hz, 
1F). 13C NMR (75 MHz, CDCl3): δ 144.59, 144.18, 144.15, 143.16, 
142.09, 142.03, 138.76, 134.41, 133.81, 133.37, 132.24, 131.90, 129.48, 
128.04, 127.56, 126.97, 126.70, 126.64, 126.49, 123.97, 123.54, 122.53. 
IR νmax (CH2Cl2)/cm
-1: 1010, 1094, 1273, 1282, 1494, 1520, 1942, 2962, 
3004, 3056, 3063, 3415. UV-Vis λmax (CH2Cl2)/nm (log ε): 408 (3.9), 528 
(2.9), 553 (2.7).  LR-MS (ESI): m/z (C45H23F5N4ORu) calcd. 832.08 found 
[M-CO] 804.04. Elemental analysis calc. for C45H23F5N4ORu C, 64.98; H, 
2.79; C, 6.74; found C, 65.25; H, 3.09; N, 6.62.  
Ru(2)(CO) 61% yield. 1H NMR (300 MHz, CDCl3): δ 8.71 – 8.36 (m, 8H, 
Hβpyrr), 8.34 – 8.12 (m, 9H, HAr), 7.80 – 7.58 (m, 16H, HAr), 7.40 – 7.26 
(m, 77H, HAr + Hsolvent), 5.16 – 3.67 (br, 29H, Hsugar). 
19F NMR (282 MHz, 
CDCl3): δ -137.94 – -140.21 (m, 2F), -156.17 – -157.34 (m, 2F). 
13C NMR 
(75 MHz, CDCl3): δ 135.01, 134.93, 129.05, 128.98, 128.85, 128.82, 
128.78, 128.72, 128.70, 128.65, 128.56, 128.52, 128.48, 128.43, 128.40, 
128.37, 128.28, 128.23, 128.19, 128.17, 128.13, 128.08, 128.04, 128.00, 
127.95, 127.80, 127.76, 127.70, 127.62, 127.51, 127.16, 127.10, 105.18, 
105.08, 102.79, 102.53, 85.23, 84.73, 84.36, 84.10, 83.34, 83.14, 83.07, 
82.44, 82.18, 82.11, 81.13, 75.43, 75.29, 74.86, 74.38, 73.32, 71.98, 
71.51, 57.56, 57.49, 57.44. IR νmax (CH2Cl2)/cm
-1: 1009, 1095, 1262, 
1275, 1282, 1941, 2926, 2960, 2986, 3051, 3060. UV-Vis λmax 
(CH2Cl2)/nm (log ε): 406 (5.1), 527 (3.8), 550 (3.6). LR-MS (ESI) m/z 
(C100H82F4N4O12Ru) calcd. 1708.40, found [M+K]
+ 1746.7. Elemental 
analysis calc. for C100H82F4N4O12Ru C, 70.29; H, 4.84; N, 3.28; found: C, 
70.49; H, 5.05; N, 3.22.  
Synthesis of Ru(3)(CO). NaH 60% wt (166.4 mg, 4.16 mmol) was 
added under nitrogen to a toluene (14.0 mL) solution of Ru(F20TPP)(CO) 
(115.0 mg, 0.104 mmol) and 1 (290.0 mg, 0.624 mmol). The solution was 
refluxed for 50 hours until the complete consumption of Ru(F20TPP)(CO) 
was observed by TLC (SiO2, n-hexane/AcOEt = 7:3) and then residual 
NaH was quenched with HCl 1.0 N. CH2Cl2 (20.0 mL) was added to the 
mixture, the organic phase was extracted with H2O until pH = 7, dried 
over Na2SO4 and filtered. The solvent was evaporated to dryness under 
vacuum and the resulting residue was purified by flash chromatography 
(SiO2, gradient elution from n-hexane to n-hexane/AcOEt = 6:4) to yield 
the red solid Ru(3)(CO) (197.0 mg, 39%). 1H NMR (400 MHz, CDCl3): δ 
8.30 - 8.24 (m, 8H,Hβpyrr), 7.44 – 7.23 (m, 187H, HAr + Hsolvent), 5.10 (t, J = 
11.9 Hz, 9H, Hsugar), 4.92 – 4.73 (m, 40H, Hsugar), 4.64 (dd, J = 20.9, 9.4 
Hz, 14H, Hsugar), 4.50 (d, J = 11.6 Hz, 10H, Hsugar), 4.34 (d, J = 7.5 Hz, 
6H, Hsugar), 4.17 – 4.08 (m, 9H, Hsugar), 3.96 – 3.87 (m, 10H, Hsugar), 3.78 
– 3.60 (m, 15H, Hsugar), 3.58 – 3.48 (m, 25H, Hsugar), 3.46 – 3.39 (m, 12H, 
Hsugar). 
19F NMR (376 MHz, CDCl3): δ -138.18 – -140.32 (m, 8F), -155.84 
– -156.90 (m, 8F). 13C NMR (100 MHz, CDCl3) δ 144.00, 139.21, 138.68, 
138.49, 138.25, 138.16, 128.65, 128.59, 128.43, 128.30, 128.12, 128.07, 
128.01, 127.79, 127.75, 127.56, 127.39, 127.31, 104.81, 102.12, 83.73, 
83.00, 82.67, 81.76, 80.94, 76.43, 75.31, 75.20, 75.00, 74.97, 74.90, 
74.55, 73.64, 73.58, 69.46, 68.05, 57.11. IR νmax (CH2Cl2)/cm
-1: 1080, 
1270, 1360, 1420, 1497, 1954, 2871, 2987, 3052. UV-Vis λmax 
(CH2Cl2)/nm (log ε): 408 (5.1), 528 (3.9), 550 (3.7). MS (MALDI) m/z: 
(C265H246F16N4O45Ru) calcd.  4609.59, found [M-CO] 4581.8. Elemental 
analysis calc. for C265H246F16N4O45Ru: C, 69.01; H, 5.38; N, 1.21, found 
C, 69.30; H, 5.56, N, 1.19. 
Synthesis of Ru(7)(CO). Ru3CO12 (2.13 x 10
–1 mmol) was added to a 
toluene (15.0 mL) solution of 7 (7.12 x 10–2 mmol) under nitrogen. The 
solution was refluxed in pressure tube for 8 hours until the complete 
consumption of 7 was observed by TLC (SiO2, CH2Cl2/n-hexane = 1:1). 
The solvent was evaporated to dryness under vacuum and the resulting 
residue was purified by flash chromatography (SiO2, gradient elution from 
n-hexane/AcOEt = 7:3 to n-hexane/AcOEt = 1:1) to yield the brown solid 
Ru(7)(CO) (197.0 mg, 19%). 1H and 13C NMR spectra (400 MHz, CDCl3) 
were not well-resolved. IR νmax (CH2Cl2)/cm
-1: 1094, 1420, 1520, 1582, 
1680, 1681, 1948, 2023, 2305, 2855, 2958, 3054. UV-Vis λmax 
(CH2Cl2)/nm (log ε): 417 (5.1), 535 (4.1), 598 (3.7). HR-MS (MALDI) m/z: 
(C201H189N20O29Ru) calcd. 3448.30, found [M-CO] 3418.2 Elemental 
Analysis calc. for C201H189N20O29Ru  C, 70.00; H, 5.49; N, 8.12; found: C, 
70.29; H, 5.70; N, 7.96. 
General procedure for cyclopropanation reactions. Method A: In a 
typical run, the catalyst (6.79 x 10–4 mmol) was dissolved in 2.0 mL of dry 
toluene before adding the alkene (3.39 mmol) and the diazo compound 
(7.47 x 10–1 mmol) under nitrogen. The reaction was stirred for 2 hours at 
25oC. The solution was then evaporated to dryness and the reaction 
crude was analysed by 1H-NMR spectroscopy using 2,4-dinitrotoluene as 
the internal standard. Method B: the procedure illustrated for method A 
was followed using 6.79 x 10–1 mmol of alkene. 
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General procedure for aziridination reactions. In a typical run, the 
catalyst (2.72 x 10–2 mmol) was dissolved in 6.0 mL of dry benzene 
before adding the azide (1.34 x 10–1 mmol) and the alkene (6.79 x 10–1 
mmol) under nitrogen. The resulting solution was refluxed using a 
preheated oil bath for two 2 hours. The solution was then evaporated to 
dryness and the reaction crude was analysed by 1H-NMR spectroscopy 
using 2,4-dinitrotoluene as the internal standard. 
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